Zenas BioPharma, Inc. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Zenas BioPharma, Inc. stock issued during period, value, new issues for the quarter ending 2024-09-30 was $234.39M.
- Zenas BioPharma, Inc. stock issued during period, value, new issues for fiscal 2024 was $234.30M.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2024-12-31 | $234.30M 10-K · filed 2025-03-11 | |
| 2024-09-30 | $234.39M 10-Q · filed 2025-11-12 |